JP2002502882A5 - - Google Patents

Download PDF

Info

Publication number
JP2002502882A5
JP2002502882A5 JP2000531187A JP2000531187A JP2002502882A5 JP 2002502882 A5 JP2002502882 A5 JP 2002502882A5 JP 2000531187 A JP2000531187 A JP 2000531187A JP 2000531187 A JP2000531187 A JP 2000531187A JP 2002502882 A5 JP2002502882 A5 JP 2002502882A5
Authority
JP
Japan
Prior art keywords
interleukin
suspension
mineral
carrier molecule
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000531187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002502882A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/002847 external-priority patent/WO1999040936A2/en
Publication of JP2002502882A publication Critical patent/JP2002502882A/ja
Publication of JP2002502882A5 publication Critical patent/JP2002502882A5/ja
Pending legal-status Critical Current

Links

JP2000531187A 1998-02-12 1999-02-10 インターロイキン−１２とともに処方された肺炎球菌および髄膜炎菌のワクチン Pending JP2002502882A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7452898P 1998-02-12 1998-02-12
US60/074,528 1998-02-12
PCT/US1999/002847 WO1999040936A2 (en) 1998-02-12 1999-02-10 Pneumococcal and meningococcal vaccines formulated with interleukin-12

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009193167A Division JP2010006827A (ja) 1998-02-12 2009-08-24 インターロイキン−１２とともに処方された髄膜炎菌のワクチン
JP2010144063A Division JP2010265279A (ja) 1998-02-12 2010-06-24 インターロイキン−１２とともに処方された肺炎球菌および髄膜炎菌のワクチン

Publications (2)

Publication Number Publication Date
JP2002502882A JP2002502882A (ja) 2002-01-29
JP2002502882A5 true JP2002502882A5 (enExample) 2006-03-02

Family

ID=22120049

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000531187A Pending JP2002502882A (ja) 1998-02-12 1999-02-10 インターロイキン−１２とともに処方された肺炎球菌および髄膜炎菌のワクチン
JP2009193167A Pending JP2010006827A (ja) 1998-02-12 2009-08-24 インターロイキン−１２とともに処方された髄膜炎菌のワクチン
JP2010144063A Pending JP2010265279A (ja) 1998-02-12 2010-06-24 インターロイキン−１２とともに処方された肺炎球菌および髄膜炎菌のワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009193167A Pending JP2010006827A (ja) 1998-02-12 2009-08-24 インターロイキン−１２とともに処方された髄膜炎菌のワクチン
JP2010144063A Pending JP2010265279A (ja) 1998-02-12 2010-06-24 インターロイキン−１２とともに処方された肺炎球菌および髄膜炎菌のワクチン

Country Status (9)

Country Link
EP (1) EP1053015A2 (enExample)
JP (3) JP2002502882A (enExample)
KR (1) KR100585408B1 (enExample)
CN (1) CN1200730C (enExample)
AU (1) AU759391B2 (enExample)
BR (1) BR9907884A (enExample)
CA (1) CA2320223A1 (enExample)
IL (2) IL137809A0 (enExample)
WO (1) WO1999040936A2 (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320223A1 (en) * 1998-02-12 1999-08-19 American Cyanamid Company Pneumococcal and meningococcal vaccines formulated with interleukin-12
US6908757B1 (en) 1998-03-26 2005-06-21 The Procter & Gamble Company Serine protease variants having amino acid deletions and substitutions
US6946128B1 (en) 1999-07-22 2005-09-20 The Procter & Gamble Company Protease conjugates having sterically protected epitope regions
CN1373802A (zh) 1999-07-22 2002-10-09 宝洁公司 在特定表位区域具有氨基酸缺失和取代的枯草杆菌蛋白酶变体
BR0012660A (pt) 1999-07-22 2002-04-09 Procter & Gamble Variante de protease tipo subtilisina; composição de limpeza; e composição de cuidado pessoal
MXPA02000842A (es) 1999-07-22 2002-07-30 Procter & Gamble Conjugados de proteasa que tienen sitios de corte protegidos estericamente.
SI2353608T1 (sl) 2002-10-11 2020-12-31 Glaxosmithkline Biologicals Sa Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam
PT2172213E (pt) 2003-01-30 2013-06-03 Novartis Ag Vacinas injetáveis contra múltiplos serogrupos meningocócicos
CA2540896C (en) 2003-10-02 2015-06-02 Chiron Srl Liquid vaccines for multiple meningococcal serogroups
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
PL1740217T3 (pl) 2004-04-30 2012-03-30 Novartis Ag Szczepienie koniugatem meningokokowym
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
GB0410866D0 (en) 2004-05-14 2004-06-16 Chiron Srl Haemophilius influenzae
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0502095D0 (en) 2005-02-01 2005-03-09 Chiron Srl Conjugation of streptococcal capsular saccharides
SI2351772T1 (sl) 2005-02-18 2016-11-30 Glaxosmithkline Biologicals Sa Proteini in nukleinske kisline iz Escherichia coli povezane z meningitisom/sepso
NZ599345A (en) 2005-02-18 2013-07-26 Novartis Vaccines & Diagnostic Immunogens from uropathogenic Escherichia Coli
US7955605B2 (en) * 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN113198012B (zh) * 2005-04-08 2024-09-17 惠氏有限责任公司 多价肺炎球菌多糖－蛋白质缀合物组合物
WO2006123164A2 (en) * 2005-05-19 2006-11-23 The Edward Jenner Institute For Vaccine Research Lps-binding and bactericidal cytokines and interferons
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
JP2010500399A (ja) 2006-08-16 2010-01-07 ノバルティス アーゲー 尿路病原性大腸菌由来の免疫原
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
ES2532946T3 (es) 2008-02-21 2015-04-06 Novartis Ag Polipéptidos PUfH meningocócicos
US8568732B2 (en) 2009-03-06 2013-10-29 Novartis Ag Chlamydia antigens
CA3154626A1 (en) 2009-04-14 2010-10-21 Glaxosmithkline Biologicals S.A. Compositions for immunising against staphylococcus aureus
US10988511B2 (en) 2009-07-07 2021-04-27 Glaxosmithkline Biologicals Sa Conserved Escherichia bacterial IG-like domain (group 1) protein (ORF405) immunogens
SG178035A1 (en) 2009-07-16 2012-03-29 Novartis Ag Detoxified escherichia coli immunogens
CN104650241A (zh) 2009-08-27 2015-05-27 诺华股份有限公司 包括脑膜炎球菌fHBP序列的杂交多肽
AU2010293902A1 (en) 2009-09-10 2012-03-22 Novartis Ag Combination vaccines against respiratory tract diseases
GB0917002D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Improved shigella blebs
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
AU2010352695B2 (en) 2009-09-30 2014-08-21 Glaxosmithkline Biologicals S.A. Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
US20130022639A1 (en) 2009-09-30 2013-01-24 Novartis Ag Expression of meningococcal fhbp polypeptides
GB0918392D0 (en) 2009-10-20 2009-12-02 Novartis Ag Diagnostic and therapeutic methods
CN102917730A (zh) 2009-10-27 2013-02-06 诺华有限公司 修饰的脑膜炎球菌fHBP多肽
GB0919690D0 (en) 2009-11-10 2009-12-23 Guy S And St Thomas S Nhs Foun compositions for immunising against staphylococcus aureus
ES2707778T3 (es) 2009-12-30 2019-04-05 Glaxosmithkline Biologicals Sa Inmunógenos polisacáridos conjugados con proteínas portadoras de E. coli
GB201003333D0 (en) 2010-02-26 2010-04-14 Novartis Ag Immunogenic proteins and compositions
GB201005625D0 (en) 2010-04-01 2010-05-19 Novartis Ag Immunogenic proteins and compositions
BR112012025364A2 (pt) 2010-04-07 2015-09-22 Novartis Ag método para geração de partícula semelhante a vírus de parvovírus b19
GB201009861D0 (en) 2010-06-11 2010-07-21 Novartis Ag OMV vaccines
CN103154242B (zh) 2010-07-06 2015-09-30 诺华股份有限公司 诺如病毒衍生的免疫原性组合物和方法
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
GB201017519D0 (en) 2010-10-15 2010-12-01 Novartis Vaccines Inst For Global Health S R L Vaccines
WO2012072769A1 (en) 2010-12-01 2012-06-07 Novartis Ag Pneumococcal rrgb epitopes and clade combinations
US20130315959A1 (en) 2010-12-24 2013-11-28 Novartis Ag Compounds
ES2687129T3 (es) 2011-07-25 2018-10-23 Glaxosmithkline Biologicals Sa Composiciones y métodos para evaluar la inmunogenicidad funcional de vacunas contra parvovirus
GB201114923D0 (en) 2011-08-30 2011-10-12 Novartis Ag Immunogenic proteins and compositions
EP2755994A2 (en) 2011-09-14 2014-07-23 Novartis AG Escherichia coli vaccine combination
WO2013038375A2 (en) 2011-09-14 2013-03-21 Novartis Ag Methods for making saccharide-protein glycoconjugates
CA2858519A1 (en) 2011-12-08 2013-06-13 Novartis Ag Clostridium difficile toxin-based vaccine
WO2013108272A2 (en) 2012-01-20 2013-07-25 International Centre For Genetic Engineering And Biotechnology Blood stage malaria vaccine
MX2014010011A (es) 2012-02-24 2014-09-08 Novartis Ag Proteinas y composiciones de pilus.
CN108671228A (zh) 2012-04-26 2018-10-19 诺华股份有限公司 抗原和抗原组合
US10279026B2 (en) 2012-04-26 2019-05-07 Glaxosmithkline Biologicals Sa Antigens and antigen combinations
US10124051B2 (en) 2012-05-22 2018-11-13 Glaxosmithkline Biologicals Sa Meningococcus serogroup X conjugate
EP2897635A1 (en) 2012-09-18 2015-07-29 Novartis AG Outer membrane vesicles
SG11201502197XA (en) 2012-10-02 2015-04-29 Glaxosmithkline Biolog Sa Nonlinear saccharide conjugates
MX2015002483A (es) 2012-10-03 2016-01-08 Glaxosmithkline Biolog Sa Composiciones inmunogenicas.
CA2892688A1 (en) 2012-11-30 2014-06-05 Glaxosmithkline Biologicals Sa Pseudomonas antigens and antigen combinations
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN114544913B (zh) * 2022-02-23 2024-04-09 沈阳建筑大学 一种土壤调查加密采样布点优化方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5571515A (en) * 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
WO1996001273A1 (en) * 1994-07-01 1996-01-18 Rican Limited Helicobacter pylori antigenic protein preparation and immunoassays
MX9702396A (es) * 1994-10-05 1997-12-31 Univ Vanderbilt Interleukina-12 como adyuvante para vacunas de paramyxoviridae.
GB9422990D0 (en) * 1994-11-15 1995-01-04 Cortecs Ltd Immunogenic compositions
US5866134A (en) * 1995-03-24 1999-02-02 Schering Corporation Method for enhancing the antibody response to specific antigens with Interleukin-10
AU5507098A (en) * 1995-12-19 1998-03-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Enhancement of dna immunization through the use of cytokines
EP1015026B1 (en) * 1996-05-31 2006-05-10 National University of Ireland, Maynooth Il-12 as an adjuvant for bordetella pertussis vaccines
US6438586B1 (en) * 1996-09-30 2002-08-20 Emc Corporation File transfer utility which employs an intermediate data storage system
CA2320223A1 (en) * 1998-02-12 1999-08-19 American Cyanamid Company Pneumococcal and meningococcal vaccines formulated with interleukin-12
US6303114B1 (en) * 1998-03-05 2001-10-16 The Medical College Of Ohio IL-12 enhancement of immune responses to T-independent antigens

Similar Documents

Publication Publication Date Title
JP2002502882A5 (enExample)
CA2366314A1 (en) Protein d from haemophilus influenzae as a carrier protein in combination vaccines
WO2002000249A3 (en) Multivalent vaccine composition
JP2004501873A5 (enExample)
JP2007516219A5 (enExample)
JP2005508849A5 (enExample)
BR112019026192B1 (pt) Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas
RU2012116119A (ru) Множественная вакцинация, включающая менингококки серогруппы с
JP2005504718A5 (enExample)
RU2009134033A (ru) Жидкие вакцины для множественных серогрупп менингококков
WO2002058737A3 (en) Multivalent meningococcal polysaccharide-protein conjugate vaccine
SG168517A1 (en) Pneumococcal polysaccharide conjugate vaccine
MX336934B (es) Composicion conjugada polisacarido-proteina neumococica multivalente.
JP2009525260A5 (enExample)
CA2392880A1 (en) Compositions comprising neisseria meningitidis antigens from serogroups b and c
JPH04230634A (ja) 複合ワクチンのキヤリヤー分子としての、百日咳菌の繊維状赤血球凝集素
TW200719911A (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
AR040922A1 (es) Composicion inmunogenica multivalente, uso de la misma para la fabricacion de un medicamento y procedimiento para preparar dicha composicion inmunogenica multivalente
JP2011042693A5 (enExample)
RU2004136295A (ru) Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку
JP2006528936A5 (enExample)
JP2002542204A5 (enExample)
WO2005000345A3 (en) Immunization method against neisseria meningitidis serogroups a and c
Makela Conjugate vaccines-a breakthrough in vaccine development
JP2003510292A5 (enExample)